Sigue la actividad de operaciones con información privilegiada más reciente de Johnson & Johnson. Mantente informado sobre las compras, ventas e impacto en el mercado recientes de las acciones de Johnson & Johnson.
La actividad de uso de información privilegiada involucra a personas con información privilegiada de la empresa, como ejecutivos, directores y empleados, que participan en transacciones con acciones de su propia empresa. Las transacciones de compra y venta de los iniciados proporcionan información valiosa sobre su confianza en el desempeño futuro de la empresa.
En Johnson & Johnson, la reciente actividad interna ha llamado la atención. Durante los últimos 30 días, los insiders han informado que han vendido un total de - acciones por valor de -, mientras tanto, los insiders han no reportar compras en los últimos 30 días.
Aug 18, 2025 | EXEC VP, CFO | 0.00 | $139.39 | -$1.26M | SELL-OPTIONS | 0.00% | 16.14K | Aug 15 | ||
Jul 18, 2025 | EVP, INNOVATIVE MEDICINE, R&D | -19.14K | $163.55 | -$3.13M | SELL | -64.23% | 10.66K | Jul 17 | ||
Feb 26, 2025 | VP CORPORATE CONTROLLER | 0.00 | $133.88 | -$448.01K | SELL-OPTIONS | 0.00% | 21.14K | Feb 25 | ||
Feb 18, 2025 | EVP, WW CHAIR, MEDTECH | 2.06K | $156.30 | -$193.03K | SELL-OPTIONS | 15.78% | 15.10K | Feb 13 - Feb 18 | ||
Feb 11, 2025 | EXEC VP, CFO | 0.00 | $126.97 | -$700.60K | SELL-OPTIONS | 0.00% | 2.11K | Feb 07 | ||
Dec 12, 2024 | DIRECTOR | 1.00K | $147.22 | $147.22K | BUY | ∞ | 1.00K | Dec 12 | ||
Sep 03, 2024 | VP CORPORATE CONTROLLER | 0.00 | $132.56 | -$366.27K | SELL-OPTIONS | 0.00% | 19.11K | Aug 30 | ||
Mar 13, 2024 | EVP, GLOBAL CORP AFFAIRS | -8.89K | $162.16 | -$1.44M | SELL | -37.15% | 15.04K | Mar 13 | ||
Feb 12, 2024 | EVP, WW CHAIR, PHARMACEUTICALS | 1.83K | $123.36 | -$4.21M | SELL-OPTIONS | 1.31% | 141.42K | Feb 08 - Feb 09 | ||
Jul 27, 2023 | EXEC VP, CHIEF HR OFFICER | -20.00K | $170.32 | -$3.41M | SELL | -16.30% | 102.70K | Jul 25 | ||
Jul 27, 2023 | SEE REMARKS | 0.00 | $131.22 | -$1.20M | SELL-OPTIONS | 0.00% | 87.75K | Jul 26 | ||
Jun 14, 2023 | EVP, CHIEF TO AND RISK OFFICER | -12.46K | $160.00 | -$1.99M | SELL | -15.84% | 66.21K | Jun 12 | ||
Mar 08, 2023 | SEE REMARKS | -1.06K | $154.66 | -$164.20K | SELL | -10.33% | 9.22K | Mar 06 | ||
Dec 15, 2022 | EXEC VP, CFO | -46.00 | $133.90 | -$1.35M | SELL | -0.12% | 37.80K | Apr 20 - Dec 13 | ||
Dec 02, 2022 | EVP, WW CHAIR, MEDTECH | 0.00 | $124.00 | -$7.55M | SELL-OPTIONS | 0.00% | 42.11K | Nov 30 | ||
Nov 23, 2022 | EVP, WW CHAIR, PHARMACEUTICALS | 0.00 | $124.66 | -$8.02M | SELL-OPTIONS | 0.00% | 126.46K | Nov 22 | ||
Nov 21, 2022 | CONTROLLER, CAO | 0.00 | $132.72 | -$1.43M | SELL-OPTIONS | 0.00% | 15.61K | Nov 18 | ||
Nov 10, 2022 | EVP, CHIEF GSC OFFICER | 0.00 | $122.98 | -$1.66M | SELL-OPTIONS | 0.00% | 71.59K | Nov 09 | ||
Nov 08, 2022 | EXEC VP, WW CHAIR, CONSUMER | 0.00 | $150.97 | -$1.42M | SELL-OPTIONS | 0.00% | 40.13K | Nov 04 | ||
Oct 26, 2022 | EXEC VP, CHIEF HR OFFICER | -29.27K | $171.36 | -$5.02M | SELL | -20.34% | 114.68K | Oct 24 | ||
Oct 26, 2022 | EXEC VP, CHIEF HR OFFICER | -20.85K | $171.19 | -$3.57M | SELL | -12.65% | 143.95K | Oct 24 | ||
Oct 26, 2022 | EXEC VP, CHIEF HR OFFICER | -13.00K | $171.22 | -$2.23M | SELL | -7.31% | 164.80K | Oct 24 | ||
Oct 26, 2022 | EXEC VP, CHIEF HR OFFICER | -8.26K | $171.14 | -$1.41M | SELL | -4.39% | 179.90K | Oct 24 | ||
Oct 26, 2022 | EXEC VP, CHIEF HR OFFICER | -4.26K | $171.13 | -$729.52K | SELL | -2.25% | 184.86K | Oct 24 | ||
Oct 26, 2022 | EXEC VP, CHIEF HR OFFICER | 75.64K | $143.35 | $8.59M | SELL-OPTIONS | 66.25% | 189.82K | Oct 24 | ||
Oct 26, 2022 | SEE REMARKS | 0.00 | $130.99 | -$1.22M | SELL-OPTIONS | 0.00% | 80.24K | Oct 24 | ||
Oct 21, 2022 | EXEC VP, CHIEF HR OFFICER | -22.86K | $164.50 | -$3.76M | SELL | -16.62% | 114.68K | Oct 19 | ||
Oct 21, 2022 | EXEC VP, CHIEF HR OFFICER | -29.95K | $164.50 | -$4.93M | SELL | -18.02% | 136.24K | Oct 19 | ||
Oct 21, 2022 | EXEC VP, CHIEF HR OFFICER | -13.70K | $164.50 | -$2.25M | SELL | -7.56% | 167.49K | Oct 19 | ||
Oct 21, 2022 | EXEC VP, CHIEF HR OFFICER | 66.51K | $133.19 | $6.55M | SELL-OPTIONS | 58.00% | 181.19K | Oct 19 | ||
Jun 14, 2022 | EVP, CHIEF GSC OFFICER | 0.00 | $122.77 | -$4.02M | SELL-OPTIONS | 0.00% | 71.59K | Jun 10 | ||
May 31, 2022 | CONTROLLER, CAO | 0.00 | $126.27 | -$909.33K | SELL-OPTIONS | 0.00% | 15.61K | May 26 | ||
Apr 25, 2022 | SEE REMARKS | 0.00 | $137.01 | -$2.77M | SELL-OPTIONS | 0.00% | 80.24K | Apr 21 | ||
Mar 21, 2022 | EXEC VP, WW CHAIR, CONSUMER | -23.68K | $176.25 | -$4.17M | SELL | -37.11% | 40.13K | Mar 17 | ||
Mar 21, 2022 | EXEC VP, WW CHAIR, CONSUMER | 19.91K | $138.48 | $1.18M | SELL-OPTIONS | 45.35% | 63.81K | Mar 17 | ||
Mar 17, 2022 | CONTROLLER, CAO | 0.00 | $124.02 | -$514.83K | SELL-OPTIONS | 0.00% | 15.61K | Mar 15 | ||
Dec 09, 2021 | CONTROLLER, CAO | 0.00 | $117.88 | -$453.35K | SELL-OPTIONS | 0.00% | 14.35K | Dec 07 | ||
Dec 10, 2020 | — | 0.00 | $107.57 | -$4.96M | OPTION EXERCISE | 0.00% | 57.35K | Dec 09 | ||
Sep 04, 2020 | — | 0.00 | $108.63 | -$1.45M | OPTION EXERCISE | 0.00% | 58.70K | Sep 02 |
Explora operaciones con información privilegiada sobre todos los valores.